582 related articles for article (PubMed ID: 9486577)
41. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
[TBL] [Abstract][Full Text] [Related]
42. Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basis.
Lokich JJ; Moore CL; Anderson NR
Cancer; 1996 Jul; 78(2):300-3. PubMed ID: 8674007
[TBL] [Abstract][Full Text] [Related]
43. [Adriamycin, cyclophosphamide, ftorafur and tamoxifen (ACFT) in patients with advanced breast cancer].
Imajo K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Ozeki H; Nagamine D; Shinagawa K; Fukutani H
Gan To Kagaku Ryoho; 1988 Jan; 15(1):121-6. PubMed ID: 3122665
[TBL] [Abstract][Full Text] [Related]
44. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil combined with high-dose folinic acid. An update.
Machover D; Goldschmidt E; Schwarzenberg L; Vanden-Bulcke JM; Misset JL; Chollet P; Mathé G
Chemioterapia; 1985 Oct; 4(5):369-76. PubMed ID: 3878231
[TBL] [Abstract][Full Text] [Related]
45. [The clinical efficacy of CAC regimen in the treatment of advanced breast cancer].
Zhang P; Zhou J; Feng F
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):365-7. PubMed ID: 8697977
[TBL] [Abstract][Full Text] [Related]
46. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
Pannuti F; Iafelice G; Martoni A; Fruet F; Angelelli B; Casadei M
Chemioterapia; 1984 Aug; 3(4):216-9. PubMed ID: 6398121
[TBL] [Abstract][Full Text] [Related]
47. Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancer.
Closon MT; Verbeke L; Kains JP; Tijtgat J; Schallier D
Anticancer Res; 1995; 15(2):591-5. PubMed ID: 7539240
[TBL] [Abstract][Full Text] [Related]
48. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Benavides M; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L
NCI Monogr; 1987; (5):193-8. PubMed ID: 3501542
[TBL] [Abstract][Full Text] [Related]
49. Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer.
Solé LA; Albanell J; Bellmunt J; Ribas A; Gallego OS; Carulla J
Cancer; 1995 Feb; 75(3):831-5. PubMed ID: 7828134
[TBL] [Abstract][Full Text] [Related]
50. Palliative chemotherapy in metastatic colorectal carcinoma: comparison of two chemotherapeutic regimens.
Bremnes RM; Wist EA
Anticancer Res; 1996; 16(2):921-6. PubMed ID: 8687152
[TBL] [Abstract][Full Text] [Related]
51. Levo folinic acid and 5-fluorouracil plus high dose epidoxorubicin as first line treatment for metastatic breast carcinoma.
Gebbia V; Testa A; Valenza R; Cipolla C; Amato C; Latteri M; Gebbia N; Florena M
Anticancer Res; 1993; 13(1):141-4. PubMed ID: 8386492
[TBL] [Abstract][Full Text] [Related]
52. A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.
Schwartz GK; Christman K; Saltz L; Casper E; Quan V; Bertino J; Martin DS; Colofiore J; Kelsen D
Cancer; 1996 Nov; 78(9):1988-95. PubMed ID: 8909321
[TBL] [Abstract][Full Text] [Related]
53. Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.
Feliu J; González Barón M; Espinosa E; García Girón C; de la Gándara I; Espinosa J; Colmenarejo A; Jalón JI; Fernández Y; de Castro J
Cancer; 1997 May; 79(10):1884-9. PubMed ID: 9149013
[TBL] [Abstract][Full Text] [Related]
54. [A study of complete responders in cases of metastatic breast cancer treated with combination chemotherapy].
Shinagawa K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Mizunuma N
Gan No Rinsho; 1989 Apr; 35(5):581-6. PubMed ID: 2541272
[TBL] [Abstract][Full Text] [Related]
55. [A randomized trial of adriamycin, cyclophosphamide, ftorafur (ACF) and adriamycin, cyclophosphamide, ftorafur, methotrexate (ACFM) in patients with advanced breast cancer].
Inoue K; Ogawa M; Inagaki J; Horikoshi N; Ikeda K; Nakada H; Usui N; Adachi K; Tada A; Yamazaki H
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1832-7. PubMed ID: 6433805
[TBL] [Abstract][Full Text] [Related]
56. [5-fluorouracil, high dose folinic acid and mitomycin C in the treatment of advanced digestive cancers].
Seitz JF; Diaw A; Giovannini M; Perrier H; Gouvernet J
Bull Cancer; 1994 Feb; 81(2):134-7. PubMed ID: 7894119
[TBL] [Abstract][Full Text] [Related]
57. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone.
Tannir N; Yap HY; Hortobagyi GH; Hug V; Buzdar AU; Blumenschein GR
Cancer Treat Rep; 1984; 68(7-8):1039-41. PubMed ID: 6547638
[TBL] [Abstract][Full Text] [Related]
58. A phase I study of UFT-oral vinorelbine in metastatic breast cancer.
Ferrero JM; Largillier R; Michel C; Amiot V; Milano G; Hébert C; Mari V; Courdi A; Figl A; Follana P; Barrière J; Chamorey E
Oncology; 2011; 81(2):73-8. PubMed ID: 21968516
[TBL] [Abstract][Full Text] [Related]
59. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
[TBL] [Abstract][Full Text] [Related]
60. [Comparison of the therapeutic effect of CMxMF and CAMF regimens in the management of advanced breast cancer patients].
Chen JA
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):202-4. PubMed ID: 8261866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
